Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Steven Black, et al. - This combined DTaP–IPV appeared safe and immunogenic when given as a booster dose at 4–6 years of age. The DTaP–IPV vaccine had no negative effect on the response to co-administered MMR vaccine, making it well-suited for use as a pre-school booster


Previous Article Next Article

Today in Peds Allergy/Immunology...keeping you current

Home use of albuterol for asthma exacerbations
Annals of Allergy, Asthma, and Immunology, 06/09/09

The Efficacy of Montelukast during the Allergy Season in Pediatric Patients with Persistent Asthma and Seasonal Aeroallergen Sensitivity
Journal of Asthma, 06/04/09

Diagnostic Criteria for Eosinophilic Esophagitis: A 5-year Retrospective Review in a Pediatric Population
Journal of Pediatric Gastroenterology and Nutrition, 06/29/09

Today in Vaccine/Immunotherapy...keeping you current

Serious Bacterial Infections in Febrile Infants in the Post–Pneumococcal Conjugate Vaccine Era
Academic Emergency Medicine, 06/17/09

Vaccination-associated anaphylaxis in adults: Diagnostic testing ruling out IgE-mediated vaccine allergy
Vaccine , 06/11/09

Aplastic Anemia Following Varicella Vaccine
Pediatric Infectious Disease Journal, 06/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address